HPRA, JAZMP inspect Divi’s Laboratories’ Unit-2 Vishakhapatnam

31 Aug 2019

Divi’s Laboratories’ Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from August 26, 2019 to August 30, 2019. The inspection at site was focused on general GMP. The inspection has concluded successfully with no critical observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Related Divis Laboratories Ltd. Links:

Divis Lab Share Price

1657.80 0.00 (0.00%) Nov 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 410.05
Lupin 738.25
Dr. Reddys Lab 2734.00
Piramal Enterprises 1758.75
Cadila Healthcare 234.20
View more..
Sensex vs Divis Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463